New Treatment Options for Advanced Melanoma

Published Online: Wednesday, September 26, 2012
Follow Pharmacy_Times:
In this video from Memorial Sloan-Kettering Cancer Center, several experts discuss new treatments for melanoma, including vemurafenib (Zelboraf), which targets the activity of mutated BRAF genes found in approximately half of melanoma tumors, and ipilimumab (Yervoy), which uses the immune system to fight melanoma. The participants in the discussion include Paul Chapman, MD, an oncologist and melanoma expert, and Charlotte Ariyan, MD, PhD, a surgeon specializing in surgical oncology who conducts research into immunotherapy for cancer.

Related Articles
After years of debate and regulatory hurdles, a milestone was achieved today when the FDA approved the first biosimilar in the United States.
Since patients with Barrett’s esophagus seem to progress to cancerous stages faster than others, health care professionals might perceive that controlling acid reflux would prevent the transition.
The FDA announced today that it has expanded the indication of Bristol-Myers Squibb’s anticancer medication nivolumab (Opdivo) to include the treatment of patients with metastatic squamous non-small cell lung cancer with progression on or after platinum-based chemotherapy.
Teva Pharmaceutical Industries recently launched generic versions of Sanofi’s enoxaparin sodium injection (Lovenox) and Pfizer’s linezolid injection (Zyvox).
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$